| 2024-03-18 21:01 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.08 | Shares Delisted from TSX222 | IntelliPharmaCeutics to be delisted from TSX |
| 2024-03-18 20:20 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.08 | New Listing5 | IntelliPharmaCeutics lists on NEX |
| 2024-03-13 17:33 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.08 | News Release200 | IntelliPharmaCeutics stuck on NEX over disclosures |
| 2024-03-06 15:00 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.08 | News Release200 | IntelliPharmaCeutics receives cease trade order |
| 2024-03-06 07:43 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.08 | Halt Trading170 | IntelliPharmaCeutics International halted at the open |
| 2024-02-08 16:51 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.09 | News Release200 | IntelliPharmaCeutics grants options to buy 1.91M shares |
| 2024-01-02 17:47 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.06 | News Release200 | IntelliPharmaCeutics receives cond. OK to list on TSX-V |
| 2023-10-16 18:45 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.09 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-10-16 18:42 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.09 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-10-16 17:34 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.09 | News Release200 | IntelliPharmaCeutics loses $1.88-million (U.S.) in Q3 |
| 2023-09-14 17:23 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.11 | News Release200 | IntelliPharmaCeutics holders re-elect five directors |
| 2023-07-14 16:31 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.07 | News Release200 | IntelliPharmaCeutics loses $54,121 (U.S.) in Q2 2023 |
| 2023-07-14 16:21 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.07 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-07-14 16:20 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.07 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-06-15 13:05 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.065 | SEDAR Annual Report803 | SEDAR Annual Report |
| 2023-06-08 13:21 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.075 | Resume Trading385 | IntelliPharmaCeutics to resume at 10:45 a.m. PT |
| 2023-06-06 11:56 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.075 | News Release200 | IntelliPharmaCeutics loses $2.89M (U.S.) in 2022 |
| 2023-06-05 22:52 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.075 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-06-05 22:51 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.075 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-06-05 22:44 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.075 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
| 2023-06-05 22:44 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.075 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2023-06-05 22:42 | CC:IPCI | IntelliPharmaCeutics International Inc (2) | 0.075 | SEDAR MD & A815 | SEDAR MD & A |